Medical Science Liaison

Overview

We are a global, family-owned company driven by a passion for innovation. Building on our foundational expertise in carbohydrate chemistry and cell cycle biology, we develop innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders. With 700+ employees across the UK, Ireland, the Nordics, Germany, the USA, and China, we are committed to scientific excellence, patient care, and collaborative partnerships with the medical community.

Our Core Values

• People-Driven – We are a family-held company built on passionate, knowledgeable people. We value integrity, open-mindedness and respect and are guided by these values in all our endeavors. We respect each individual who becomes a part of our journey, from our employees and partners to our end-users. We recognize that the strength in all our collaborations is trust.
• Committed to Quality – Quality is our source of inspiration. Quality drives our results. It represents our aspiration for excellence and our focus on driving continual improvements. For our partners and end-users, quality must always be tangible in our products, processes and people. This way, quality is the promise we keep every day.
• Innovating for Better Lives – Innovation is essential in our quest to improve the lives of humans. We seek to address unmet needs through our expertise in iron and carbohydrate-based pharmaceuticals. We believe in a holistic and collaborative approach to research and innovation, so we work together with the scientific and medical communities to set new standards.

We have continued our growth trajectory since we launched our first product in the US, Monoferric® (ferric derisomaltose), through acquisitions, partnerships, and pipeline. Our R&D investments continue to leverage our core competencies, alongside our recent advancements in cancer care. Join us in shaping the future of patient care through innovation and collaboration.

The Medical Science Liaison (MSL) is a field-based scientific professional who serves as an extension of the Medical Affairs organization. The MSL works throughout a product's lifecycle, helping to ensure that products are utilized safely and effectively, serves as a scientific resource within the medical community, establishes, develops, cultivates and maintains peer-to-peer relationships with Key Opinion Leaders (KOLs) at major academic institutions and clinics and is a scientific expert to internal colleagues at the company.

The primary responsibility of the MSL is the balanced exchange of medical information and education with KOLs and health care professionals (HCPs) involved with the disease states Pharmacosmos currently has approved treatments or is involved in drug development. The role of an MSL is non-promotional in nature. The MSL works to shape patient care through Pharmacosmos’ medicines, research and health economic activities.

• Develop and maintain comprehensive clinical acumen related to PTI therapeutic areas of interest to support pipeline and marketed PTI products
• Identify, develop, and engage Key Opinion Leaders (KOLs) within regional territory to support US and global Medical Affairs initiatives
• Lead scientific discussions, leveraging both the clinical and economic (HEOR) totality of evidence for PTI products, with regional population health decision makers and other key stakeholders to broaden awareness of PTI therapies and to support accurate EHR integration in clinical pathways, formularies, and order sets
• Collect actionable insights for internal stakeholders to inform, adjust, or validate existing PTI strategies and tactics
• Represent PTI at high priority conferences, professional association meetings, and other events to identify emerging trends and maximize scientific discussion with external stakeholders
• Respond to unsolicited medical information requests (MIRFs) with appropriate documentation
• Facilitate the submission and review of unsolicited Investigator Sponsored Studies (ISSs) in alignment with evidence generation and publication plans
• Engage KOL pool to support critical medical affairs activities, inclusive of advisory…